Showing results (121-130 of 192) with videos related to
Sort By:
Pageof 20
Biomaterials|August 6, 2013
Microfabricated polymeric vessel mimetics for 3-D cancer cell cultureAshley A Jaeger, Chandan K Das, Nicole Y Morgan, et al.Anticancer Research|November 29, 2005
Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistanceXing-Jie Liang, Barbara Taylor, Carol Cardarelli, et al.Journal of Medicinal Chemistry|June 11, 2011
Collateral sensitivity of multidrug-resistant cells to the orphan drug tioproninAndrew S Goldsborough, Misty D Handley, Andrés E Dulcey, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2015
Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoproteinLora D Weidner, King Leung Fung, Pavitra Kannan, et al.Cancer|May 16, 2013
Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneityChirayu Patel, Leif Stenke, Sudhir Varma, et al.Journal of the National Cancer Institute|August 26, 2009
Influence of melanosome dynamics on melanoma drug sensitivityKevin G Chen, Richard D Leapman, Guofeng Zhang, et al.Experimental Cell Research|January 20, 2004
Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cellsXing-Jie Liang, Jun-Jie Yin, Jien-Wei Zhou, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|September 2, 2015
Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogsJustin C Jagodinsky, Agnieszka Sulima, Yiqi Cao, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 5, 2016
An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matterPavitra Kannan, Martin Schain, Warren W Kretzschmar, et al.Journal of the National Cancer Institute|October 12, 2010
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristicsAnna Maria Calcagno, Crystal D Salcido, Jean-Pierre Gillet, et al.Pageof 20